MetaCap

Madison Square Garden Sports Corp. Class A (MSGS)

NYSE: MSGSCommunication ServicesEntertainmentUSD

404.97+2.90 (+0.72%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

After hours: 404.97 +0.00%

MSGS stock chart

Technical analysis

Key statistics

All statistics
P/E (TTM)
1,265.53
Ex-dividend date
Oct 14, 2022
52-week range
207.90 – 438.93
Day range
398.01 – 409.86
Volume / Avg
263.03K / 240.72K
Beta
—
Next earnings
Oct 30, 2026

52-week range

$207.90$438.93

MSGS stock today

Shares of Madison Square Garden Sports (MSGS) finished higher on Oct 7 at $404.97, a gain of 0.72% or $2.90 per share, versus the S&P 500's 0.22% decline. At this level, MSGS sits near the top of its 52-week range of $207.90 to $438.93: 7.7% below the high, set on Aug 13, 2026 and 94.8% above the low. MSGS is up 58.1% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 86.3%.

At 1,266x trailing earnings, Madison Square Garden Sports's P/E ratio is unusually high because its trailing profit is very small relative to its share price. Madison Square Garden Sports's next earnings report is expected on Oct 30, 2026.

Summary generated from market data by MetaCap's automated system. Methodology

About Madison Square Garden Sports

Company profile

Madison Square Garden Sports Corp. operates as a professional sports company in the United States. It owns and operates a portfolio of assets that consists of the New York Knickerbockers of the National Basketball Association (NBA) and the New York Rangers of the National Hockey League.

Industry
Entertainment
CEO
Mr. James Lawrence Dolan
Headquarters
New York, NY
Employees
522
IPO year
2015

Financial highlights

Full financials

In fiscal 2026, Madison Square Garden Sports generated $1.15 billion in revenue, up 11.0% from fiscal 2025, its 5th consecutive year of revenue growth. Net income was $7.8 million, for a net margin of 0.7% versus a median of 5.4% in the prior 5 years. Operating margin was 2.5%.

Madison Square Garden Sports annual revenue, net income and EPS
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue$1.15B$1.04B$1.03B$887.45M$821.35M
Growth+11.03%+1.18%+15.74%+8.05%+97.57%
Net income$7.76M$-22.44M$58.77M$47.79M$51.13M
EPS (diluted)$0.32$-0.93$2.44$1.89$2.10

Analyst forecast

Forecast

Consensus (8 analysts)

buy

Avg. price target

$480.67+18.69%

  • Strong buy 2
  • Buy 3
  • Hold 3
  • Sell 0
  • Strong sell 0

Target range

Low $415.00High $584.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Next report
Oct 30, 2026
EPS estimate
$-1.18
Last reported (Q4 2026)
Aug 13, 2026
EPS actual vs est.
$1.18 vs —

Dividends

Dividend history
Annual dividend
$0.00
Last payment
$7.00
Ex-dividend date
Oct 14, 2022

MSGS news

All MSGS news

Madison Square Garden Sports peers

Communication Services sector

Indexes, lists and sector

Madison Square Garden Sports stock FAQ

What is Madison Square Garden Sports's stock price today?

MSGS last traded at $404.97 as of Oct 7, 4:00 PM EDT, up 0.72% on the day. Prices are delayed at least 15 minutes.

Does Madison Square Garden Sports pay a dividend?

Yes. Madison Square Garden Sports pays $0.00 per share annually. The most recent dividend of $7.00 had an ex-dividend date of Oct 14, 2022.

When is Madison Square Garden Sports's next earnings date?

Madison Square Garden Sports is expected to report earnings on Friday, October 30, 2026. Analysts expect EPS of $-1.18.

What is MSGS's P/E ratio?

MSGS trades at a trailing P/E ratio of 1265.53, compared with a median of 21.4 for its closest peers.

Who is Madison Square Garden Sports's CEO?

Mr. James Lawrence Dolan is the chief executive officer of Madison Square Garden Sports Corp. Class A, which has about 522 employees.

Has MSGS ever split its stock?

Yes. The most recent MSGS stock split was a 1402-for-1000 split on Apr 20, 2020.

What is the MSGS 52-week high?

The 52-week high for MSGS is $438.93 and the 52-week low is $207.90. The stock is currently 7.7% below its high.

Compare MSGS